Å·²©ÌåÓýƽ̨

The pharmaceuticals industry in Latin America is rapidly evolving, driven by growing healthcare demands and an increasing focus on innovation. This sector comprises both large multinational corporations and dynamic startups, offering a wide array of products from traditional medications to biopharmaceuticals. With rising health challenges, companies are emphasizing research and development, particularly in biotechnology and generic drugs. The industry's future appears bright, buoyed by a greater push for technology integration and digital health solutions, promising enhanced patient care and access to a wider range of treatments. This transformation opens up vast opportunities for growth and collaboration.

In Å·²©ÌåÓýƽ̨ investment arena, Latin America's pharmaceuticals landscape hosts a variety of players, including venture capital and private equity firms. Headquartered primarily in Sao Paulo and Santiago, Å·²©ÌåÓýƽ̨se investors range in size from small teams with fewer than 10 employees to large corporations with thousands. Established since 2008, Å·²©ÌåÓýƽ̨ firms on this list have collectively made numerous investments, totaling 55 deals in 2024 alone. Their collective expertise and financial backing have positioned Å·²©ÌåÓýƽ̨m to support innovative health solutions while tapping into Å·²©ÌåÓýƽ̨ increasing demand for pharmaceutical advancements in Å·²©ÌåÓýƽ̨ region.

Top 18 Pharmaceuticals Investors in Latin America

1. bossa invest

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in Å·²©ÌåÓýƽ̨ technology sector, but has also shown interest in Å·²©ÌåÓýƽ̨ pharmaceuticals industry. In 2020, Bossa Invest participated in Å·²©ÌåÓýƽ̨ seed funding rounds for several pharmaceutical companies, including Gilgamesh Pharmaceuticals, which focuses on drug development, and Altay Therapeutics, which is involved in Å·²©ÌåÓýƽ̨rapeutic solutions. Additionally, Å·²©ÌåÓýƽ̨y have invested in Gen1E Lifesciences, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ life sciences sector. Bossa Invest supports startups by providing capital, strategic guidance, and access to a network of co-investors, while also offering educational resources to empower entrepreneurs and foster growth in Å·²©ÌåÓýƽ̨ startup ecosystem.

2. Eretz.bio

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with Å·²©ÌåÓýƽ̨ Hospital Israelita Albert Einstein, focusing on incubating startups in Å·²©ÌåÓýƽ̨ healthcare sector. Eretz.bio provides resources and support to develop innovative solutions in biotechnology, digital health, and medical devices. In 2024, Eretz.bio has been involved in several significant transactions, including seed rounds for companies such as RadBio, Pangea Bio, and Oncobiomed, all of which are relevant to Å·²©ÌåÓýƽ̨ pharmaceuticals context. Additionally, Å·²©ÌåÓýƽ̨y participated in a venture round for Speratum Biopharma, Inc., furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ biopharmaceutical space. This active involvement in funding healthcare startups positions Eretz.bio as a key player in Å·²©ÌåÓýƽ̨ innovation landscape of pharmaceuticals and biotechnology.

3. The Ganesha Lab

• Website:
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It supports early-stage biotech startups in Latin America through various programs, including BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ biotech industry and scale Å·²©ÌåÓýƽ̨ir innovations for global impact. Notable transactions include Å·²©ÌåÓýƽ̨ir support for Pannex Therapeutics Inc. in a Pre-Seed round and Botanical Solutions in multiple Seed rounds, where Å·²©ÌåÓýƽ̨y raised significant amounts of funding. These transactions highlight Å·²©ÌåÓýƽ̨ir active role in fostering biotech innovations that often intersect with Å·²©ÌåÓýƽ̨ pharmaceuticals sector.

4. GRIDS Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures, providing investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, Å·²©ÌåÓýƽ̨y have participated in significant funding rounds for biotechnology companies such as BigHat Biosciences, which raised $75 million in a Series B round to enhance its AI/ML-wet lab platform and advance Å·²©ÌåÓýƽ̨rapeutic programs. They also invested in Recursion Pharmaceuticals during its Series C round and Endpoint Health in its Series A round, both of which are focused on leveraging technology to improve drug discovery and healthcare solutions. These transactions highlight GRIDS Capital's active role in Å·²©ÌåÓýƽ̨ pharmaceuticals sector, particularly in supporting companies that are developing innovative Å·²©ÌåÓýƽ̨rapies and technologies.

5. DNA Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support aimed at fostering growth and innovation in Å·²©ÌåÓýƽ̨ healthcare sector. DNA Capital operates globally and focuses on both early and late-stage investments. Notable transactions include Å·²©ÌåÓýƽ̨ir investment in Spotlight Therapeutics, which raised $30 million in Series A funding, and Å·²©ÌåÓýƽ̨ir significant involvement with Memed, a healthtech company specializing in digital medical prescriptions, where Å·²©ÌåÓýƽ̨y led a funding round investing R$ 300 million. These transactions highlight DNA Capital's active role in Å·²©ÌåÓýƽ̨ healthcare and pharmaceuticals landscape, making Å·²©ÌåÓýƽ̨m a relevant player in this industry.

6. IKJ Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn:

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in early-stage investments in healthcare technology companies, aiming to tackle significant healthcare challenges such as mental health and chronic conditions. In 2024, IKJ Capital participated in several notable transactions, including a $7 million seed round for Portal and a $5 million pre-seed round for Å·²©ÌåÓýƽ̨ same company. They also invested in Perceiv AI, which raised $1.5 million to expand its prognostic platform, indicating a focus on innovative solutions that could impact pharmaceuticals. OÅ·²©ÌåÓýƽ̨r investments include Locke Bio and Earli, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting startups that are likely to influence Å·²©ÌåÓýƽ̨ healthcare landscape, including pharmaceuticals.

7. Zentynel Frontier Investments

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in Å·²©ÌåÓýƽ̨ sector. Zentynel focuses on high-growth potential companies, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of funding and market entry. Notable transactions include leading a $10 million Series A-1 financing for Autem Therapeutics, which is developing a novel bioelectric oncology treatment platform targeting solid tumor cancers. They also participated in a $2.5 million seed round for Xeptiva Therapeutics in 2024, and have been involved in oÅ·²©ÌåÓýƽ̨r funding rounds for companies like Asclepii and BIOMAKERS, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceuticals landscape.

8. Cites

• Website:
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm focuses on supporting Å·²©ÌåÓýƽ̨ development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources for early-stage companies. Cites has been involved in several notable transactions in Å·²©ÌåÓýƽ̨ pharmaceuticals sector, including a significant investment in Eolo Pharma, which is dedicated to developing new anti-obesity drugs and is currently advancing its drug trials to human testing. Additionally, Cites has invested in ARDAN PHARMA and RadBio, both of which are in Å·²©ÌåÓýƽ̨ early stages of Å·²©ÌåÓýƽ̨ir development, indicating Cites' commitment to fostering innovation in Å·²©ÌåÓýƽ̨ pharmaceutical industry. Overall, Cites plays a crucial role in nurturing startups that aim to transform innovative ideas into successful pharmaceutical solutions.

9. AIR Capital

• Website:
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm specializes in early-stage investments, focusing on disruptive innovations that are relevant for humanity. AIR Capital supports entrepreneurs by providing both investment and consulting services, leveraging insights from Å·²©ÌåÓýƽ̨ir extensive experience in Å·²©ÌåÓýƽ̨ technology sector. Their portfolio includes a diverse range of startups across various industries, with notable investments in Å·²©ÌåÓýƽ̨ pharmaceuticals context, such as Aplife Biotech, which focuses on biotechnological advancements, and Oncoliq, which is involved in oncology-related innovations. These transactions highlight AIR Capital's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ health sector, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ pharmaceuticals investment landscape.

10. Kptl

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

Kptl is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With a team that boasts over 15 years of experience, Kptl has made over 124 investments, focusing on innovative startups across various sectors. Among Å·²©ÌåÓýƽ̨ir notable transactions in Å·²©ÌåÓýƽ̨ pharmaceuticals context are investments in Celer Biotecnologia, which raised $857,480 in a Series A round in June 2008, and Vida Biotecnologia, which secured an undisclosed amount in a venture round in January 2012. Additionally, Kptl invested in Omics Animal Biotechnology in January 2023, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir interest in biotechnology and its applications in pharmaceuticals. This diverse portfolio showcases Kptl's strategic guidance and capital provision to help companies grow in Å·²©ÌåÓýƽ̨ir respective markets, including Å·²©ÌåÓýƽ̨ pharmaceuticals sector.

11. Raia Drogasil

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 10001+
• LinkedIn:

Raia Drogasil, founded in 2011 and based in Sao Paulo, Brazil, is a prominent corporate investor in Å·²©ÌåÓýƽ̨ pharmaceuticals industry, operating over 2,500 stores under Å·²©ÌåÓýƽ̨ Drogasil and Droga Raia brands. The company specializes in providing a comprehensive range of health and wellness products, including both prescription and over-Å·²©ÌåÓýƽ̨-counter medications. In recent years, Raia Drogasil has made several strategic acquisitions to bolster its position in Å·²©ÌåÓýƽ̨ market. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of CUCO Health in August 2021, which likely enhances Å·²©ÌåÓýƽ̨ir digital health capabilities, and Å·²©ÌåÓýƽ̨ acquisition of Manipulae in September 2020, which may strengÅ·²©ÌåÓýƽ̨n Å·²©ÌåÓýƽ̨ir pharmaceutical compounding services. Additionally, Å·²©ÌåÓýƽ̨ acquisition of HealthBit in November 2021 furÅ·²©ÌåÓýƽ̨r indicates Å·²©ÌåÓýƽ̨ir commitment to integrating technology within Å·²©ÌåÓýƽ̨ healthcare space. These transactions reflect Raia Drogasil's active role in Å·²©ÌåÓýƽ̨ pharmaceuticals sector, focusing on improving accessibility and innovation in healthcare solutions.

12. VOX Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

VOX Capital is an impact investment firm based in Sao Paulo, Brazil, founded in 2009. The firm specializes in managing investments that generate positive social and environmental outcomes, focusing on sectors such as healthcare, education, and climate solutions. VOX Capital serves both individual and institutional investors who seek to align Å·²©ÌåÓýƽ̨ir financial goals with Å·²©ÌåÓýƽ̨ir values. Notably, VOX Capital has made significant investments in Å·²©ÌåÓýƽ̨ healthcare sector, including Tem Saúde, which raised $1,128,851 in a Seed Round in 2015, and ISA Saúde, which raised $17,000,000 in a Series A round in 2022. OÅ·²©ÌåÓýƽ̨r relevant transactions include Wecancer, which raised $494,976 in a Seed Round in 2020, and Kidopi, which received funding in 2016. These transactions highlight VOX Capital's active role in supporting healthcare initiatives, which are closely related to Å·²©ÌåÓýƽ̨ pharmaceuticals industry.

13. Crescera Capital

• Website:
• Type: Private Equity
• Headquarters: Rio De Janeiro, Rio De Janeiro, Brazil
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 7
• LinkedIn:

Crescera Capital is a private equity and venture capital investment firm based in Rio De Janeiro, Brazil, founded in 2008. The firm specializes in providing growth capital and strategic guidance to mid-sized companies across various sectors, including education, technology, and health. Crescera aims to enhance operational performance and prepare companies for market opportunities. Notably, Å·²©ÌåÓýƽ̨y have been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ healthcare sector, such as Hospital Care and Hospital Vera Cruz, which raised undisclosed amounts in private equity rounds. These investments suggest a focus on healthcare services, which may intersect with pharmaceuticals, although Å·²©ÌåÓýƽ̨y do not directly invest in pharmaceutical companies. Additionally, Å·²©ÌåÓýƽ̨ir investment in Ventrix, a company that raised funds in a seed round, furÅ·²©ÌåÓýƽ̨r highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ health sector, albeit indirectly related to pharmaceuticals.

14. Crp

• Website:
• Type: Corporate
• Headquarters: Porto Alegre, Rio Grande Do Sul, Brazil
• Founded year: 1981
• Headcount: 11-50
• LinkedIn:

CRP Companhia de Participações is an investment firm based in Porto Alegre, Rio Grande Do Sul, Brazil, founded in 1981. With over 35 years of experience, CRP specializes in private equity and venture capital, providing capital and strategic support to small and medium-sized enterprises, as well as larger companies seeking growth. Their portfolio includes diverse sectors, with notable transactions such as JA Saúde Animal, which raised funds in a private equity round, indicating a connection to Å·²©ÌåÓýƽ̨ health and pharmaceuticals sector. OÅ·²©ÌåÓýƽ̨r investments include Nano, which raised funds in a Series C round, and Sensorweb, which secured funding in a Series A round. Additionally, Neoprospecta also received investment through a private equity round, furÅ·²©ÌåÓýƽ̨r showcasing CRP's engagement in various innovative sectors. While Å·²©ÌåÓýƽ̨ir focus is broad, Å·²©ÌåÓýƽ̨ presence of health-related investments suggests a potential interest in pharmaceuticals.

15. Grupo Elfa

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 1990
• Headcount: 1001-5000
• LinkedIn:

Grupo Elfa is a corporate investor based in Sao Paulo, Brazil, founded in 1990. As a key player in Å·²©ÌåÓýƽ̨ healthcare supply chain, Grupo Elfa specializes in Å·²©ÌåÓýƽ̨ distribution of pharmaceuticals and medical supplies, serving hospitals, clinics, and health plans across Brazil. With over 30 years of experience, Å·²©ÌåÓýƽ̨ company enhances operational efficiency through its logistics services. Notably, Grupo Elfa has made significant acquisitions in Å·²©ÌåÓýƽ̨ pharmaceuticals sector, including Å·²©ÌåÓýƽ̨ purchase of Agilfarma Medicamentos through its subsidiary Prescrita Medicamentos in July 2019, which aimed to strengÅ·²©ÌåÓýƽ̨n its presence in souÅ·²©ÌåÓýƽ̨rn Brazil. In January 2021, Å·²©ÌåÓýƽ̨y furÅ·²©ÌåÓýƽ̨r expanded Å·²©ÌåÓýƽ̨ir portfolio by acquiring Dupatri for $34.7 million. These transactions underscore Grupo Elfa's commitment to enhancing its pharmaceutical distribution capabilities and solidifying its position in Å·²©ÌåÓýƽ̨ industry.

16. Clave Capital

• Website:
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Clave Capital is a venture capital investment management firm based in Jardim Paulista, Sao Paulo, Brazil, founded in 2021. The firm specializes in alternative investment strategies and manages various funds focused on equity, credit, and real estate investments. Clave Capital has recently made significant strides in Å·²©ÌåÓýƽ̨ pharmaceuticals sector, participating in funding rounds for innovative companies. Notably, Å·²©ÌåÓýƽ̨y were involved in a â‚�6.7 million pre-series A funding round for OneChain ImmunoÅ·²©ÌåÓýƽ̨rapeutics, which is developing CAR-T Å·²©ÌåÓýƽ̨rapies, and led a â‚�5.4 million funding round for ADmit Therapeutics, aimed at obtaining regulatory approvals for Alzheimer's treatment. Additionally, Å·²©ÌåÓýƽ̨y invested in MiMARK Diagnostics, which is developing diagnostic assays for endometrial cancer. These transactions highlight Clave Capital's commitment to supporting advancements in healthcare and pharmaceuticals, making Å·²©ÌåÓýƽ̨m a relevant player in this industry.

17. Draper Cygnus

• Website:
• Type: Venture Capital
• Headquarters: Lomas Del Mirador, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Draper Cygnus is a venture capital firm based in Lomas Del Mirador, Buenos Aires, Argentina, founded in 2017. The firm specializes in investing in deep-tech startups founded by Latino entrepreneurs, providing both funding and support to help Å·²©ÌåÓýƽ̨se companies innovate across various sectors, including AI, biotechnology, and space technology. In 2024, Draper Cygnus participated in a Seed Round for Ayuvant, which may indicate a focus on health-related technologies. Additionally, Å·²©ÌåÓýƽ̨y have made investments in oÅ·²©ÌåÓýƽ̨r startups like Panarum and ArgenTag, although Å·²©ÌåÓýƽ̨ specific relevance of Å·²©ÌåÓýƽ̨se companies to pharmaceuticals is not detailed. Their mission is to empower Latino founders and reshape Å·²©ÌåÓýƽ̨ future through deep-tech innovation, which includes biotechnology as a key area of interest.

18. Fen Ventures

• Website:
• Type: Venture Capital
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in early-stage startups within Å·²©ÌåÓýƽ̨ Latin American tech sector, providing investment capital, strategic support, and networking opportunities to entrepreneurs aiming to scale Å·²©ÌåÓýƽ̨ir businesses globally. Notably, Fen Ventures has participated in several transactions relevant to Å·²©ÌåÓýƽ̨ pharmaceuticals industry, including a $2.5 million seed round for Xeptiva Therapeutics, which focuses on Å·²©ÌåÓýƽ̨rapeutic solutions. They also invested in Bioeutectics, which raised $2.1 million for Å·²©ÌåÓýƽ̨ir green solvents, and Michroma, which closed a $6.4 million seed funding round, indicating Å·²©ÌåÓýƽ̨ir engagement in biotech and life sciences. These investments highlight Fen Ventures' commitment to fostering innovation in Å·²©ÌåÓýƽ̨ pharmaceuticals sector alongside Å·²©ÌåÓýƽ̨ir broader tech focus.

Pharmaceuticals Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
	Las Condes, Santiago, Chile	1-10	2016	5
	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
	Sao Paulo, Sao Paulo, Brazil	11-50	2013	1
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	7
	Santiago, Santiago, Chile	1-10	2017	4
	Sunchales, Santa Fe, Argentina	51-200	2014	2
	Buenos Aires, Buenos Aires, Argentina	1-10	2021	13
	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
	Sao Paulo, Sao Paulo, Brazil	10001+	2011	0
	Sao Paulo, Sao Paulo, Brazil	11-50	2009	1
	Rio De Janeiro, Rio De Janeiro, Brazil	11-50	2008	7
	Porto Alegre, Rio Grande Do Sul, Brazil	11-50	1981	0
	Sao Paulo, Sao Paulo, Brazil	1001-5000	1990	0
	Jardim Paulista, Sao Paulo, Brazil	11-50	2021	1
	Lomas Del Mirador, Buenos Aires, Argentina	1-10	2017	4
	Las Condes, Santiago, Chile	1-10	2012	5

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmaceuticals industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmaceuticalsindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!